GSK and NUVL Stocks Put Biotech M&A and Patent Cliff Deals in Focus for Investors
The sudden $10.6 billion acquisition of Nuvalent NASDAQ: NUVL by GSK NYSE: GSK violently shatters a lingering mergers…
Barclays sees a short-squeeze brewing in this corner of the market as the Iran war winds down
Barclays thinks a peace deal with Iran could trigger a short-squeeze in key areas of the market. Consumer…
Iran Peace Deal Could Trigger a Short-Squeeze in This Sector, Barclays Says
A beaten-down area of the market could soon be headed for a meme-like rally, Barclays says. Investors have…